Fig. 3From: Clinical outcomes and hemodynamic performance of Dafodil™ aortic and mitral pericardial bioprosthesis: 1-year results from Dafodil-1 first-in-human trial(a) Outcomes of PCS and MCS scores of SF12v1 at pre-procedure, and post-procedure till 12-month in AVR group (b) Outcomes of PCS and MCS scores of SF12v1 at pre-procedure, and post-procedure till 12-month in MVR groupBack to article page